Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Kinesiotaping in Isolated Meniscus Injuries

4 de mayo de 2026 actualizado por: Nurten NAS KIRDAR, Bandırma Onyedi Eylül University

The Effect of Kinesiotaping on Pain and Functionality in Isolated Meniscus Injuries: A Randomized Controlled Study

The effect of kinesiotaping on pain and functionality in isolated meniscus injuries.

Descripción general del estudio

Descripción detallada

Our study was designed as a randomized controlled trial. All patients presenting to the Physical Medicine and Rehabilitation outpatient clinic with knee pain and meeting the inclusion criteria will be included in the study after being informed and giving their consent. Patients' age, gender, and body mass index will be recorded. Patients will be divided into three groups using stratified randomization. An attempt will be made to ensure a homogeneous distribution of patients in terms of gender, age, and body mass index. Group 1 will receive standard treatment, Group 2 will receive standard treatment + kinesiotaping, and Group 3 will receive standard treatment + sham taping. Standard treatment will consist of strengthening exercises for the quadriceps and hamstring muscles, stretching exercises around the knee, proprioceptive exercises, and activity modification. These exercises will be taught to the patient and they will be asked to perform them at home five days a week for three weeks. Kinesiotaping and sham taping will be applied three times, once every five days. Kinesiotaping will be applied to the group with a specific tension and technique (quadriceps facilitation technique, "Y" tape shape, applied with 25-50% tension), while the sham group will have the tape simply applied to the skin without any tension (perpendicular to the quadriceps muscle, tension-free). Kinesiotapes do not contain any medication; their effect depends on the technique (facilitation, inhibition, etc.) and tension level (10%, 25%, 50%, 75%). All patients will have VAS and WOMAC parameters evaluated before treatment, on day 20, and at month 3 after treatment.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

75

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Nurten NAS KIRDAR, Assistant Professor
  • Número de teléfono: +905415511691
  • Correo electrónico: nkirdar@bandirma.edu.tr

Ubicaciones de estudio

      • Balıkesir, Turquía (Türkiye)
        • Reclutamiento
        • Bandırma Onyedi Eylul University Faculty of Medicine
        • Contacto:

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto

Acepta Voluntarios Saludables

No

Descripción

Inclusion Criteria:

  • Ages 18-50
  • Knee pain lasting longer than 2 weeks
  • Having a diagnosis of isolated meniscus injury (grade 1, 2 or 3 meniscus degeneration) confirmed by magnetic resonance imaging (MRI)
  • Not having undergone knee surgery in the last 6 months
  • Not having received intraarticular injections in the knee area
  • Being willing to participate in the study

Exclusion Criteria:

  • Trauma history
  • Anterior or posterior cruciate ligament injury
  • Collateral ligament injuries
  • Advanced knee osteoarthritis
  • Rheumatic or neurological disease
  • Allergy or skin condition to kinesiotape
  • History of intraarticular injection
  • Neuromuscular dysfunction
  • Rheumatological disease
  • Cognitive dysfunction

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Exercises
Standard treatment will consist of strengthening exercises for the quadriceps and hamstring muscles, stretching exercises around the knee, proprioceptive exercises, and activity modification. These exercises will be taught to the patient and they will be asked to perform them at home five days a week for three weeks.
rengthening exercises for the quadriceps and hamstring muscles, stretching exercises around the knee, proprioceptive exercises, and activity modification.
Experimental: kinesiotaping
Kinesiotaping will be applied three times, once every five days. Kinesiotaping will be applied to the group with a specific tension and technique (quadriceps facilitation technique, "Y" tape shape, applied with 25-50% tension). Kinesiotapes do not contain any medication; their effect depends on the technique (facilitation, inhibition, etc.) and tension level (10%, 25%, 50%, 75%).
Kinesiotaping will be applied three times, once every five days. Kinesiotaping will be applied to the group with a specific tension and technique (quadriceps facilitation technique, "Y" tape shape, applied with 25-50% tension). Kinesiotapes do not contain any medication; their effect depends on the technique (facilitation, inhibition, etc.) and tension level (10%, 25%, 50%, 75%).
Experimental: sham taping
Sham taping will be applied three times, once every five days. The sham group will have the tape simply applied to the skin without any tension (perpendicular to the quadriceps muscle, tension-free). Kinesiotapes do not contain any medication; their effect depends on the technique (facilitation, inhibition, etc.) and tension level (10%, 25%, 50%, 75%).
sham taping will be applied three times, once every five days. the sham group will have the tape simply applied to the skin without any tension (perpendicular to the quadriceps muscle, tension-free). Kinesiotapes do not contain any medication; their effect depends on the technique (facilitation, inhibition, etc.) and tension level (10%, 25%, 50%, 75%).

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
VAS
Periodo de tiempo: 3 months
The VAS (Visual Analog Scale) will be used to determine the severity of knee pain. The VAS is a reliable and easily applicable scale accepted worldwide in the literature for measuring the severity of pain in patients. The Visual Analog Scale is used to convert values that cannot be measured numerically into numerical values. It is a scale where the starting point is -0- "no pain" and the other end is -10- "very severe pain," with numerical values assigned to each centimeter (cm) in one-centimeter increments.
3 months
WOMAC
Periodo de tiempo: 3 months
The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) is a widely used, valid, and reliable index for evaluating patients with osteoarthritis. It is also very commonly used in knee problems other than osteoarthritis to assess knee pain and knee function. It is a recommended metric for osteoarthritis studies by the Outcome Measures in Rheumatology Clinical Trials (OMERACT). The WOMAC OA index, validated and proven reliable in Turkish by Tüzün et al., consists of three sections and 24 questions assessing pain, stiffness, and physical function. The maximum possible scores are 20 for the pain subgroup, 8 for stiffness, and 68 for physical function. Higher scores indicate increased pain and stiffness, and impaired physical function.
3 months

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Nurten NAS KIRDAR, Assistant Professor, Bandırma Onyedi Eylül University

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de abril de 2026

Finalización primaria (Estimado)

30 de octubre de 2026

Finalización del estudio (Estimado)

30 de octubre de 2026

Fechas de registro del estudio

Enviado por primera vez

28 de abril de 2026

Primero enviado que cumplió con los criterios de control de calidad

4 de mayo de 2026

Publicado por primera vez (Actual)

7 de mayo de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

7 de mayo de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

4 de mayo de 2026

Última verificación

1 de mayo de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

Once our study is completed, if it is deemed suitable for evaluation and publication in a peer-reviewed journal on the subject, all researchers will be able to access our results.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir